Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia.

Míreanna comhchosúla

• Genotype-specific MRD interpretation improves stratification in paediatric acute lymphoblastic leukaemia
  de réir: O'Connor, D, et al.
  Foilsithe / Cruthaithe: (2017)
• Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003.
  de réir: O'Connor, D, et al.
  Foilsithe / Cruthaithe: (2014)
• Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
  de réir: Vora, A, et al.
  Foilsithe / Cruthaithe: (2014)
• Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
  de réir: Vora, A, et al.
  Foilsithe / Cruthaithe: (2014)
• Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MIRD) clearance in childhood lymphoblastic leukaemia (ALL)
  de réir: Moorman, A, et al.
  Foilsithe / Cruthaithe: (2008)